Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$0.73 - $2.73 $286 - $1,070
-392 Reduced 0.85%
45,507 $106,000
Q4 2023

Feb 13, 2024

BUY
$0.38 - $0.91 $199 - $478
526 Added 1.16%
45,899 $40,000
Q3 2023

Nov 13, 2023

BUY
$0.79 - $2.83 $1,274 - $4,564
1,613 Added 3.69%
45,373 $39,000
Q2 2023

Aug 04, 2023

BUY
$2.49 - $20.59 $3,859 - $31,914
1,550 Added 3.67%
43,760 $118,000
Q1 2023

May 12, 2023

BUY
$15.95 - $25.18 $13,398 - $21,151
840 Added 2.03%
42,210 $787,000
Q4 2022

Feb 10, 2023

SELL
$13.27 - $17.73 $1,990 - $2,659
-150 Reduced 0.36%
41,370 $662,000
Q3 2022

Nov 14, 2022

BUY
$11.4 - $14.6 $6,680 - $8,555
586 Added 1.43%
41,520 $540,000
Q2 2022

Aug 12, 2022

SELL
$7.94 - $12.96 $14,434 - $23,561
-1,818 Reduced 4.25%
40,934 $432,000
Q1 2022

May 13, 2022

SELL
$12.02 - $16.79 $36,180 - $50,537
-3,010 Reduced 6.58%
42,752 $514,000
Q4 2021

Feb 11, 2022

SELL
$9.93 - $15.39 $13,594 - $21,068
-1,369 Reduced 2.9%
45,762 $645,000
Q3 2021

Nov 12, 2021

SELL
$10.18 - $26.64 $11,401 - $29,836
-1,120 Reduced 2.32%
47,131 $482,000
Q2 2021

Aug 13, 2021

SELL
$18.57 - $35.68 $165,254 - $317,516
-8,899 Reduced 15.57%
48,251 $1.29 Million
Q1 2021

May 07, 2021

SELL
$31.0 - $55.72 $29,078 - $52,265
-938 Reduced 1.61%
57,150 $1.98 Million
Q4 2020

Feb 12, 2021

BUY
$37.09 - $48.97 $285,963 - $377,558
7,710 Added 15.3%
58,088 $2.15 Million
Q3 2020

Nov 04, 2020

SELL
$40.47 - $45.5 $17,483 - $19,656
-432 Reduced 0.85%
50,378 $2.07 Million
Q2 2020

Aug 12, 2020

BUY
$32.57 - $42.83 $140,213 - $184,383
4,305 Added 9.26%
50,810 $2.06 Million
Q1 2020

May 04, 2020

SELL
$23.3 - $45.96 $62,607 - $123,494
-2,687 Reduced 5.46%
46,505 $1.62 Million
Q4 2019

Feb 05, 2020

BUY
$34.58 - $48.06 $5,947 - $8,266
172 Added 0.35%
49,192 $2.11 Million
Q3 2019

Nov 08, 2019

SELL
$36.98 - $48.45 $12,647 - $16,569
-342 Reduced 0.69%
49,020 $1.81 Million
Q2 2019

Aug 13, 2019

BUY
$35.13 - $55.53 $30,211 - $47,755
860 Added 1.77%
49,362 $2.23 Million
Q1 2019

May 06, 2019

SELL
$42.83 - $59.91 $67,328 - $94,178
-1,572 Reduced 3.14%
48,502 $2.64 Million
Q4 2018

Feb 13, 2019

BUY
$37.97 - $60.16 $18,149 - $28,756
478 Added 0.96%
50,074 $2.32 Million
Q3 2018

Nov 09, 2018

BUY
$56.3 - $67.25 $50,332 - $60,121
894 Added 1.84%
49,596 $3.01 Million
Q2 2018

Aug 08, 2018

BUY
$44.9 - $64.95 $186,290 - $269,477
4,149 Added 9.31%
48,702 $3.05 Million
Q1 2018

May 07, 2018

SELL
$45.35 - $61.65 $108,658 - $147,713
-2,396 Reduced 5.1%
44,553 $2.06 Million
Q4 2017

Feb 09, 2018

BUY
$41.95 - $60.1 $108,566 - $155,538
2,588 Added 5.83%
46,949 $2.23 Million
Q3 2017

Nov 09, 2017

BUY
$33.4 - $53.9 $1.48 Million - $2.39 Million
44,361
44,361 $2.39 Million

Others Institutions Holding FGEN

About FIBROGEN INC


  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $32.8M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.